Perakine reductase mutant and application thereof

A mutant and reductase technology, which is applied in the application field of Perakine reductase mutant, selective hydrogenation of α, β-unsaturated ketone double bond reaction, can solve the problem of unsatisfactory reaction yield and selectivity, and cannot be widely used , harsh reaction conditions, etc., to achieve mild reaction conditions, environmental friendliness, and high conversion efficiency

Active Publication Date: 2021-03-23
ZHEJIANG UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, when using chemical methods to reduce the carbon-carbon double bonds of α,β-unsaturated carbonyl compounds, it is easy to compete with carbonyl reduction, and it is challenging to achieve high regioselectivity. Currently, chemical methods mainly use transition metals as the The catalyst realizes the selective hydrogenation reaction of the carbon-carbon double bond of α, β-unsaturated carbonyl, but there are still unsatisfactory reaction yields and selectivities, the need to use hydrogen as a hydrogen source with hidden safety, harsh reaction conditions and environmental pollution and other issues
[0003] The biocatalytic reaction relying on double bond reductase is another important way to achieve carbon-carbon double bond reduction. Compared with chemical methods, it has the advantages of high efficiency, environmental protection, high selectivity, and mild reaction. The limitations of its substrate spectrum, enzyme yield, stability, catalytic efficiency, cofactors and other factors still cannot achieve its wide application at the industrial level. Therefore, it is urgent to develop new high-efficiency double bond reductases that can be applied to industrial applications.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Perakine reductase mutant and application thereof
  • Perakine reductase mutant and application thereof
  • Perakine reductase mutant and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] The mutation of embodiment 1Perakine reductase

[0024] The wild-type Perakine reductase expression plasmid has been constructed by the applicant's laboratory (Sun L, Ruppert M, Sheludko Y, Warzecha H, Zhao Y, J. Purification, cloning, functional expression and characterization of perakine reductase: the first example from the AKR enzyme family, extending the alkaloidal network of the plant Rauvolfia. Plant Mol Biol. 2008, 67(5): 455-67.) completed, its amino acid sequence As listed in SEQ ID NO.1, the nucleotide sequence is listed in SEQ NO.2. The above plasmid was heat-shocked and transformed into E.coli M15 competent cells for expression, and wild-type Perakine reductase was obtained after purification.

[0025] After consulting the literature and comparing the amino acid sequence of Perakine reductase with other members of the AKR superfamily, it was found that the amino acid at position 126 is the key site that determines the carbonyl or double bond of the AKR enz...

Embodiment 2

[0031] Expression and purification of embodiment 2.Perakine reductase mutant and glucose dehydrogenase

[0032] 1. Expression of Perakine reductase mutants

[0033] Inoculate the engineered bacteria expressing the Perakine reductase mutant successfully constructed above into LB medium containing 50 μg / ml ampicillin and 25 μg / ml kanamycin and culture with shaking at 37°C for 12 hours. Transfer to 1L LB medium containing the same concentration of ampicillin and kanamycin, when the optical density of the culture medium is OD 600 When it reaches 0.6, add isopropyl-β-D-thiogalactopyranoside (IPTG) with a final concentration of 0.3mM to induce 30h at 25°C, centrifuge the culture solution at 8000rpm for 10min, discard the supernatant medium, and take the bacteria The body was stored at -20°C until use.

[0034] 2. Expression of Glucose Dehydrogenase

[0035] In the preliminary research work, the applicant's laboratory has completed the construction of Bacillus megaterium glucose d...

Embodiment 3

[0038] Embodiment 3.Perakine reductase mutant activity detection

[0039] The Perakine reductase mutant and glucose dehydrogenase pure enzyme obtained in Example 3 were added to the reaction system at a concentration of 1 mg / ml, and 50 mM pH 7.0 Kpi was used as a buffer, and the final concentration was 0.8 mM respectively. Substrate benzylidene acetone, 1.2mM glucose, 0.02mM NADP + Shake at a constant temperature (175rpm) at 30°C for 10 hours, add an equal volume of methanol to terminate the reaction, centrifuge the reaction solution at 15,000rpm for 5 minutes, add internal standard p-nitroacetophenone, and inject high-performance liquid phase (HPLC) to detect the substrate and product Quantity is analyzed. The HPLC analysis method is: chromatograph Agilent high performance liquid chromatography 1100; chromatographic column Agilent 5HC-C18 250*4.6mm; column temperature 30°C; flow rate 1ml / min; detection wavelength 214nm; mobile phase: water 45%, acetonitrile 55%. The carbony...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a Perakine reductase mutant and an application thereof. The mutant is obtained by single mutation or 126-site and 127-site combined double mutation of a wild Perakine reductaseamino acid sequence at 126th site or 127th site: H126G / R / I / C / P / K / N / W / A / Y, and R127M / P / N / S / F, wherein ' / ' represents 'or '. On the basis of a crystal three-dimensional structure and sequence alignment,a site-specific saturation mutation technology is adopted to perform molecular modification on Perakine reductase, and screening is performed to obtain a mutant with selective reduction ketene doublebonds. A method for selective reduction of ketene double bonds by using the Perikine reductase mutant as a catalyst has the advantages of simple reaction steps, mild reaction conditions, environmental friendliness, high catalytic efficiency, simple enzyme purification, good stability, strong stereoselectivity and the like, and has good application prospects in the fields of ketene double bond reduction and synthesis of related saturated ketone drugs.

Description

technical field [0001] The invention belongs to the technical field of biochemical industry, and in particular relates to a Perakine reductase mutant and its application, especially the application of the Perakine reductase mutant in selective hydrogenation of α, β-unsaturated ketone double bonds. Background technique [0002] Selective reduction of carbon-carbon double bonds of α, β-unsaturated carbonyl compounds to retain carbonyl is an important means of synthesizing saturated carbonyl compounds, and has a wide range of applications in the field of medicine and chemical industry, such as hesperidin, turmeric and dandelion flavonoids and other saturated carbonyl compounds Natural medicines are currently mainly obtained by reducing the corresponding α,β-unsaturated carbonyl compounds. However, when using chemical methods to reduce the carbon-carbon double bonds of α,β-unsaturated carbonyl compounds, it is easy to compete with carbonyl reduction, and it is challenging to ach...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N9/04C12N15/53C12N15/70C12P7/26
CPCC12N9/0006C12N15/70C12P7/26C12Y101/01318
Inventor 孙莲莉周韵蔡圣宋紫晗曾苏
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products